Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs PHLAX overlap: 50% of top holdings shared

Bottom line

How much do XLV and PHLAX overlap?

50% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 42.8% of XLV's assets and 48.2% of PHLAX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

XLVPHLAX
Weight overlap (top 25)50%
Shared holdings9
Weight in shared holdings42.8%48.2%
Total positions6555
Expense ratio0.08%1.15%
Holdings as ofJun 30, 2026May 29, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Holdings XLV and PHLAX have in common

Holding% of XLV% of PHLAXOverlap
Eli Lilly & Co16.51%17.35%16.51%
UnitedHealth Group Inc6.57%5.87%5.87%
Merck & Co Inc5.52%6.06%5.52%
Thermo Fisher Scientific Inc3.24%4.56%3.24%
Intuitive Surgical Inc2.45%3.07%2.45%
CVS Health Corp2.30%2.52%2.30%
Vertex Pharmaceuticals Inc2.19%3.37%2.19%
Danaher Corp2.09%3.28%2.09%
Stryker Corp1.89%2.16%1.89%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Johnson & Johnson — 10.64%
  2. AbbVie Inc — 7.74%
  3. Amgen Inc — 3.40%
  4. Abbott Laboratories — 2.75%
  5. Gilead Sciences Inc — 2.73%
  6. Pfizer Inc — 2.39%
  7. Bristol-Myers Squibb Co — 2.05%
  8. Medtronic PLC — 1.75%
  9. McKesson Corp — 1.58%
  10. Elevance Health Inc — 1.46%
  11. Cigna Group/The — 1.27%
  12. Boston Scientific Corp — 1.10%
  13. Regeneron Pharmaceuticals Inc — 1.08%
  14. HCA Healthcare Inc — 1.05%
  15. Cardinal Health Inc — 0.97%

Only in PHLAX

  1. Argenx Se — 3.55%
  2. Lonza Group Ag — 3.02%
  3. (PIPA070) PGIM Core Government Money Market Fund — 2.50%
  4. Insmed Inc — 2.28%
  5. Roivant Sciences Ltd — 2.21%
  6. Sionna Therapeutics Inc — 2.01%
  7. Beone Medicines Ltd — 1.82%
  8. Vaxcyte Inc — 1.77%
  9. Align Technology Inc — 1.75%
  10. Agilent Technologies Inc — 1.73%
  11. Palvella Therapeutics Inc — 1.56%
  12. Apogee Therapeutics Inc — 1.42%
  13. Cabaletta Bio Inc — 1.35%
  14. Prudential Investment Portfolios 9 — 1.31%
  15. Newamsterdam Pharma Company Nv — 1.30%

Asset mix

Asset typeXLVPHLAX
Stocks99.7%97.8%
Cash & short-term funds0.3%3.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Country mix

CountryXLVPHLAX
US97.9%84.7%
NL—5.4%
CH—4.8%
BM—2.2%
IE2.1%—
GB—1.1%
CA—1.0%
IL—1.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 29, 2026)

Check another pair

FAQ

How much do XLV and PHLAX overlap?
About 50% by weight. 9 securities appear in both funds' top 25 holdings; they make up 42.8% of XLV's assets and 48.2% of PHLAX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and PHLAX have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Merck & Co Inc, Thermo Fisher Scientific Inc, Intuitive Surgical Inc.
Should I own both XLV and PHLAX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or PHLAX?
XLV is broader, with 65 positions versus 55 for PHLAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.